Low-risk Differentiated Thyroid Carcinoma - Literature Review And Management Guidelines [câncer Diferenciado Da Tiróide De Baixo Risco - Revisão Do Estado Atual Da Literatura E Proposta De Conduta]

dc.creatorWard L.S.
dc.creatorMarrone M.
dc.creatorCamargo R.Y.
dc.creatorWatanabe T.
dc.creatorTincani A.J.
dc.creatorMatos P.S.
dc.creatorAssumpcao L.V.M.
dc.creatorTomimori E.
dc.creatorKulcsar M.A.
dc.creatorNunes M.T.
dc.creatorNogueira C.R.
dc.creatorKimura E.T.
dc.date2006
dc.date2015-06-30T18:08:06Z
dc.date2015-11-26T14:24:18Z
dc.date2015-06-30T18:08:06Z
dc.date2015-11-26T14:24:18Z
dc.date.accessioned2018-03-28T21:26:26Z
dc.date.available2018-03-28T21:26:26Z
dc.identifier
dc.identifierArquivos Brasileiros De Endocrinologia E Metabologia. , v. 50, n. 3, p. 550 - 557, 2006.
dc.identifier42730
dc.identifier
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-33748050784&partnerID=40&md5=7717f58f25e017eacae916ae7ab01770
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/103209
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/103209
dc.identifier2-s2.0-33748050784
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1245362
dc.descriptionThe trend of increasing thyroid cancer has been recognized in Brazil as well as all over the world for several decades. The large use of simple and effective diagnostic tools has significantly contributed to this trend. It is estimated that small carcinomas found at surgery for benign thyroid disorders and by ultrasonography will be identified at grater frequency in the further years. Part of these tumors occurs in low-risk patients that may benefit of less aggressive management strategies. However, the characterization of low-risk patient is still confusing and we lack adequate markers to tell apart patients that may present a troublesome progression of the disease. Furthermore, the use of new follow-up methods has recently changed some guidelines. A multidisciplinary team, including basic scientists, endocrinologists, nuclear medicine physicians, thyroid surgeons and endocrine pathologists reviewed the pertinent literature and, based on their experience, propose some management guidelines for Brazilian patients with low-risk thyroid carcinomas.
dc.description50
dc.description3
dc.description550
dc.description557
dc.descriptionCoeli, C.M., Brito, A.S., Barbosa, F.S., Ribeiro, M.G., Sieiro, A.P., Vaisman, M., Incidence and mortality from thyroid cancer in Brazil (2005) Arq Bras Endocrinol Metab, 49, pp. 503-509
dc.descriptionParkin, D., Whwlan, S., Ferlay, J., Raymond, L., Young, J., Cancer incidence in five continents (1997) IARC Sci Publ
dc.descriptionRenshaw, A.A., Papillary carcinoma of the thyroid ≤ 1.0 cm (2005) Cancer, 105, pp. 217-219
dc.descriptionIto, Y., Tomoda, C., Uruno, T., Takamura, Y., Miya, A., Kobayashi, K., Papillary microcarcinoma of the thyroid: How should it be treated? (2004) World J Surg, 28, pp. 1115-1121
dc.descriptionIto, Y., Uruno, T., Takamura, Y., Nakano, K., Takamura, Y., Miya, A., An observation trial without surgical treatment in patients with Papillary microcarcinoma of the thyroid (2003) Thyroid, 13, pp. 381-387
dc.descriptionKovacs, G.L., Gonda, G., Vadasz, G., Ludmany, E., Uhrin, K., Gorombey, Z., Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake (2005) Thyroid, 15, pp. 152-157
dc.descriptionMatos, P.S., Ferreira, A.P.C., Ward, L.S., Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series (2006) Endocrine Pathology, , no prelo
dc.descriptionCooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2006) Thyroid, , E-pub ahead of print
dc.descriptionMazzaferri, E.L., Kloos, R.T., Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer (2001) J Clin Endocrinol Metab, 86, pp. 1447-1463
dc.descriptionMazzaferri, E.L., Jhiang, S.M., Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer (1994) Am J Med, 97, pp. 418-428
dc.descriptionSchlumberger, M.J., Diagnostic follow-up of well-differentiated thyroid carcinoma: Historical perspective and current status (1999) J Endocrinol Inves, 22, pp. 3-7
dc.descriptionHay, I.D., Bergstralh, E.J., Goellner, J.R., Ebersold, J.R., Grant, C.S., Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989 (1993) Surgery, 114, pp. 1050-1057
dc.descriptionCady, B., Papillary carcinoma of the thyroid gland: Treatment based on risk group definition (1998) Surg Oncol Clin North Am, 7, pp. 633-644
dc.descriptionShaha, A.R., Thyroid carcinoma: Implications of prognostic factors (1998) Cancer, 83, pp. 401-402
dc.descriptionHadjieva, T., Scoring patients' risk in differentiated thyroid cancer (2001) Onkologie, 24, pp. 561-568
dc.descriptionHundahl, S.A., Fleming, I.D., Fremgen, A.M., Menck, H.R., A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985-1995 (1998) Cancer, 83, pp. 2638-2648
dc.descriptionHundahl, S.A., Cady, B., Cunningham, M.P., Mazzaferri, E., McKee, R.F., Rosai, J., Initial results from a prospective cohort study of 5,583 cases of thyroid carcinoma treated in the United States during 1996. US and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study (2000) Cancer, 89, pp. 202-217
dc.descriptionKinder, B.K., Well differentiated thyroid cancer (2003) Curr Opin Oncol, 15, pp. 71-77
dc.descriptionRonga, G., Filesi, M., Montesano, T., Melacrinis, F.F., Di Nicola, A., Ventroni, G., Death from differentiated thyroid carcinoma: Retrospective study of a 40-year investigation (2002) Cancer Biother Radiopharm, 17, pp. 507-514
dc.descriptionShah, J.P., Loree, T.R., Dharker, D., Strong, E.W., Lobectomy versus total thyroidectomy for differentiated carcinoma of the thyroid: A matched-pair analysis (1993) Am J Surg, 166, pp. 331-335
dc.descriptionWanebo, H., Coburn, M., Teates, D., Cole, B., Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer (1998) Ann Surg, 227, pp. 912-921
dc.descriptionChow, S.M., Law, S.C., Mendenhall, W.M., Au, S.K., Yau, S., Yuen, K.T., Follicular thyroid carcinoma: Prognostic factors and the role of radioiodine (2002) Cancer, 95, pp. 488-498
dc.descriptionCohen, E.G., Tuttle, R.M., Kraus, D.H., Postoperative management of differentiated thyroid cancer (2003) Otolaryngol Clin North Am, 36, pp. 129-157
dc.descriptionSawka, A.M., Thephamongkhol, K., Brouwers, M., Thabane, L., Browman, G., Gerstein, H.C., A systematic review and meta-analysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer (2004) J Clin Endocrinol Metab, 89, pp. 3668-3676
dc.descriptionReynolds, J.C., Percent 131I uptake and post-therapy 131I scans: Their role in the management of thyroid cancer (1997) Thyroid, 7, pp. 281-284
dc.descriptionPacini, F., Lippi, F., Formica, N., Elisei, R., Anelli, S., Ceccarelli, C., Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels (1987) J Nucl Med, 28, pp. 1888-1891
dc.descriptionDuren, M., Siperstein, A.E., Shen, W., Duh, Q.Y., Morita, E., Clark, O.H., Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients (1999) Surgery, 126, pp. 13-19
dc.descriptionHaugen, B.R., Pacini, F., Reiners, C., Schlumberger, M., Ladenson, P.W., Sherman, S.I., A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer (1999) J Clin Endocrinol Metab, 84, pp. 3877-3885
dc.description(2003) Clinical Practice Guidelines, 1. , http://www.nccn.org/physician_gls/PDF/thyroid.pdf
dc.description(2002) British Thyroid Association & Royal College of Physicians Guidelines for the Management of Thyroid Cancer in Adults, , http://www.british-thyroid-association.org/guidelines.hm, 03
dc.descriptionSchlumberger, M., Pacini, F., Wiersinga, W.M., Toft, A., Smit, J.W., Sanchez Franco, F., Follow-up and management of differentiated thyroid carcinoma: A European perspective in clinical practice (2004) Eur J Endocrinol, 151, pp. 539-548
dc.descriptionReynolds, J.C., Percent 131I uptake and post-therapy 131I scans: Their role in the management of thyroid cancer (1997) Thyroid, 7, pp. 281-284
dc.descriptionPujol, P., Daures, J.P., Nsakala, N., Baldet, L., Bringer, J., Jaffiol, C., Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer (1996) J Clin Endocrinol Metab, 81, pp. 4318-4323
dc.descriptionCooper, D.S., Specker, B., Ho, M., Sperling, M., Ladenson, P.W., Ross, D.S., Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: Results from the National Thyroid Cancer Treatment Cooperative Registry (1998) Thyroid, 8, pp. 737-744
dc.descriptionBiondi, B., Palmieri, E.A., Fazio, S., Cosco, C., Nocera, M., Sacca, L., Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients (2000) J Clin Endocrinol Metab, 85, pp. 4701-4705
dc.descriptionSchneider, R., Reiners, C., The effect of levothyroxine therapy on bone mineral density: A systematic review of the literature (2003) Exp Clin Endocrinol Diabetes, 111, pp. 455-470
dc.descriptionGrigsby, P.W., Baglan, K., Siegel, B.A., Surveillance of patients to detect recurrent thyroid carcinoma (1999) Cancer, 85, pp. 945-951
dc.descriptionDuren, M., Siperstein, A.E., Shen, W., Duh, Q.Y., Morita, E., Clark, O.H., Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients (1999) Surgery, 126, pp. 13-19
dc.descriptionMazzaferri, E.L., Kloos, R.T., Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation? (2002) J Clin Endocrinol Metab, 87, pp. 1490-1498
dc.descriptionToubeau, M., Touzery, C., Arveux, P., Chaplain, G., Vaillant, G., Berriolo, A., Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after (131)I ablation therapy in patients with differentiated thyroid cancer (2004) J Nucl Med, 45, pp. 988-994
dc.descriptionGrigsby, P.W., Baglan, K., Siegel, B.A., Surveillance of patients to detect recurrent thyroid carcinoma (1999) Cancer, 85, pp. 945-951
dc.descriptionFranceschi, M., Kusic, Z., Franceschi, D., Lukinac, L., Roncevic, S., Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma (1996) J Nucl Med, 37, pp. 446-451
dc.descriptionFrasoldati, A., Pesenti, M., Gallo, M., Caroggio, A., Salvo, D., Valcavi, R., Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma (2003) Cancer, 97, pp. 90-96
dc.descriptionWhitley, R.J., Ain, K.B., Thyroglobulin: A specific serum marker for the management of thyroid carcinoma (2004) Clin Lab Med, 24, pp. 29-47
dc.descriptionWartofsky, L., Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin (2002) Thyroid, 12, pp. 583-590
dc.descriptionMazzaferri, E.L., Robbins, R.J., Spencer, C.A., Braverman, L.E., Pacini, F., Wartofsky, L., A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma (2003) J Clin Endocrinol Metab, 88, pp. 1433-1441
dc.descriptionPacini, F., Molinaro, E., Castagna, M.G., Agate, L., Elisei, R., Ceccarelli, C., Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma (2003) J Clin Endocrinol Metab, 88, pp. 3668-3673
dc.descriptionSpencer, C.A., Takeuchi, M., Kazarosyan, M., Wang, C.C., Guttler, R.B., Singer, P.A., Serum thyroglobulin autoantibodies: Prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma (1998) J Clin Endocrinol Metab, 83, pp. 1121-1127
dc.descriptionElisei, R., Vivaldi, A., Agate, L., Molinaro, E., Nencetti, C., Grasso, L., Low specificity of blood thyroglobulin messenger ribonucleic acid assay prevents its use in the follow-up of differentiated thyroid cancer patients (2004) J Clin Endocrinol Metab, 89, pp. 33-39
dc.descriptionJemal, A., Tiwari, R.C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Cancer statistics 2004 (2004) CA Cancer J Clin, 54, pp. 8-29
dc.descriptionBaudin, E., Do Cao, C., Cailleux, A.F., Leboulleux, S., Travagli, J.P., Schlumberger, M., Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients (2003) J Clin Endocrinol Metab, 88, pp. 1107-1111
dc.languagept
dc.publisher
dc.relationArquivos Brasileiros de Endocrinologia e Metabologia
dc.rightsaberto
dc.sourceScopus
dc.titleLow-risk Differentiated Thyroid Carcinoma - Literature Review And Management Guidelines [câncer Diferenciado Da Tiróide De Baixo Risco - Revisão Do Estado Atual Da Literatura E Proposta De Conduta]
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución